Evidence map›Paper›PMID 35083334›Full record

ArticleBioMed research international2022

Segmentation of Breast Masses in Mammogram Image Using Multilevel Multiobjective Electromagnetism-Like Optimization Algorithm.

S S Ittannavar, R H Havaldar

RetractedAbstract readRetracted Publication
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Presegmenter Cascaded Framework for Mammogram Mass Segmentation.International journal of biomedical imaging · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

S S IttannavarDepartment of Electronics and Communication Engineering, Hirasugar Institute of Technology, Nidasoshi, India.ORCID https://orcid.org/0000-0002-5346-3063
R H HavaldarDepartment of Biomedical Engineering, KLE Dr. MS Sheshgiri College of Engineering and Technology, Belagavi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent times, breast mass is the most diagnostic sign for early detection of breast cancer, where the precise segmentation of masses is important to reduce the mortality rate. This research proposes a new multiobjective optimization technique for segmenting the breast masses from the mammographic image. The proposed model includes three phases such as image collection, image denoising, and segmentation. Initially, the mammographic images are collected from two benchmark datasets like Digital Database for Screening Mammography (DDSM) and Mammographic Image Analysis Society (MIAS). Next, image normalization and Contrast-Limited Adaptive Histogram Equalization (CLAHE) techniques are employed for enhancing the visual capability and contrast of the mammographic images. After image denoising, electromagnetism-like (EML) optimization technique is used for segmenting the noncancer and cancer portions from the mammogram image. The proposed EML technique includes the advantages like enhanced robustness to hold the image details and adaptive to local context. Lastly, template matching is carried out after segmentation to detect the cancer regions, and then, the effectiveness of the proposed model is analysed in light of Jaccard coefficient, dice coefficient, specificity, sensitivity, and accuracy. Hence, the proposed model averagely achieved 92.3% of sensitivity, 99.21% of specificity, and 98.68% of accuracy on DDSM dataset, and the proposed model averagely achieved 92.11% of sensitivity, 99.45% of specificity, and 98.93% of accuracy on MIAS dataset.

Indexed as

Breast NeoplasmsMammographyAlgorithmsBreastEarly Detection of CancerFemaleHumans

Identifiers

PMID35083334
PMCPMC8786533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.